By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its first-quarter revenues rose 22 percent, while it cut its net loss 58 percent.

The Redwood City, Calif.-based pharmacogenomics test maker brought in total revenues of $41.2 million for the three-month period ended March 31, compared to $33.9 million for the first quarter of 2009. It fell short of analysts' consensus estimate of $43.4 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.